Elanco Animal Health

ELANNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$11.052 B

$22.12 -8.60%

Close of 7 Aug 2026

Revenue

$4.71B

#704 by revenue

Earnings

-$232.0M

Loss-making

Shares outstanding

499,621,830

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#32AbivaxABVX$11.3B
#33Summit TherapeuticsSMMT$11.1B
#34Elanco Animal HealthELAN$11.1B
#35Axsome TherapeuticsAXSM$10.9B
#36Dr Reddys LaboratoriesRDY$10.2B

Where these numbers come from

Share counts and financials for Elanco Animal Health are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.